• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.29% Nasdaq Down3.25%

    Enanta Pharmaceuticals, Inc. (ENTA)

    -NasdaqGS
    22.74 Down 1.21(5.05%) Feb 5, 4:00PM EST
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.8
    Mean Recommendation (last week):2.8
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:33.00
    Median Target:35.50
    High Target:45.00
    Low Target:16.00
    No. of Brokers:4

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Oct 23, 2015JMP SecuritiesUpgradeMkt PerformMkt Outperform
    Oct 23, 2015BarclaysDowngradeEqual WeightUnderweight
    Apr 6, 2015Deutsche BankInitiated Buy
    Mar 4, 2015BarclaysInitiated Equal Weight
    Aug 15, 2014FBR CapitalInitiated Outperform
    Jun 24, 2014Robert W. BairdDowngradeOutperformNeutral
    Jan 28, 2014Robert W. BairdInitiated Outperform
    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0001
    Buy2221
    Hold1113
    Underperform1110
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.